Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion
(feeds.content.dowjones.io)
1.
2.
Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar
(feeds.content.dowjones.io)
3.
Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products
(feeds.content.dowjones.io)